Advertisement
Screener

CALYPTE BIOMEDICAL CORP Selling, General and Administrative Expense

CALYPTE BIOMEDICAL CORP Selling, General and Administrative Expense

CALYPTE BIOMEDICAL CORP reported Selling, General and Administrative Expense of $710.00 thousand for the 12-month period ending 2012-12-31, per its 10-K filed 2014-06-24.

Discontinued › Expense Statement › Operating Expenses

us-gaap:SellingGeneralAndAdministrativeExpense · last filed 2014-06-24

  • CALYPTE BIOMEDICAL CORP selling, general and administrative expense for the quarter ending 2012-12-31 was $175.00K, a 1.74% increase year-over-year.
  • CALYPTE BIOMEDICAL CORP selling, general and administrative expense for the quarter ending 2012-09-30 was $169.00K, a 20.66% decline year-over-year.
  • CALYPTE BIOMEDICAL CORP selling, general and administrative expense for the quarter ending 2012-06-30 was $165.00K, a 19.51% decline year-over-year.
  • CALYPTE BIOMEDICAL CORP selling, general and administrative expense for the quarter ending 2012-03-31 was $202.00K, a 18.88% decline year-over-year.
  • CALYPTE BIOMEDICAL CORP selling, general and administrative expense for fiscal 2012 was $710.00K, a 15.38% decline from fiscal 2011.
  • CALYPTE BIOMEDICAL CORP selling, general and administrative expense for fiscal 2011 was $839.00K, a 16.02% decline from fiscal 2010.
  • CALYPTE BIOMEDICAL CORP selling, general and administrative expense for fiscal 2010 was $999.00K.
Period endSelling, General and Administrative Expense 3 monthSelling, General and Administrative Expense 6 monthSelling, General and Administrative Expense 9 monthSelling, General and Administrative Expense 12 month
2012-12-31$175.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2014-06-24
$344.00K
derived: sum of 2 quarters · filed 2014-06-24
$509.00K
derived: sum of 3 quarters · filed 2014-06-24
$710.00K
10-K · filed 2014-06-24
2012-09-30$169.00K
10-Q · filed 2012-12-31
$334.00K
derived: sum of 2 quarters · filed 2012-12-31
$535.00K
10-Q · filed 2012-12-31
$708.00K
derived: sum of 4 quarters · filed 2014-06-24
2012-06-30$165.00K
10-Q · filed 2012-08-14
$366.00K
10-Q · filed 2012-08-14
$539.00K
derived: sum of 3 quarters · filed 2014-06-24
$752.00K
derived: sum of 4 quarters · filed 2014-06-24
2012-03-31$202.00K
10-Q · filed 2012-05-15
$374.00K
derived: sum of 2 quarters · filed 2014-06-24
$587.00K
derived: sum of 3 quarters · filed 2014-06-24
$792.00K
derived: sum of 4 quarters · filed 2014-06-24
2011-12-31$172.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2014-06-24
$385.00K
derived: sum of 2 quarters · filed 2014-06-24
$590.00K
derived: sum of 3 quarters · filed 2014-06-24
$839.00K
10-K · filed 2014-06-24
2011-09-30$213.00K
10-Q · filed 2012-12-31
$418.00K
derived: sum of 2 quarters · filed 2012-12-31
$667.00K
10-Q · filed 2012-12-31
$927.00K
derived: sum of 4 quarters · filed 2012-12-31
2011-06-30$205.00K
10-Q · filed 2012-08-14
$454.00K
10-Q · filed 2012-08-14
$714.00K
derived: sum of 3 quarters · filed 2012-08-14
$967.00K
derived: sum of 4 quarters · filed 2012-08-14
2011-03-31$249.00K
10-Q · filed 2012-05-15
$509.00K
derived: sum of 2 quarters · filed 2012-05-15
$762.00K
derived: sum of 3 quarters · filed 2012-05-15
$972.00K
derived: sum of 4 quarters · filed 2012-05-15
2010-12-31$260.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-22
$513.00K
derived: sum of 2 quarters · filed 2012-03-22
$723.00K
derived: sum of 3 quarters · filed 2012-03-22
$999.00K
10-K · filed 2012-03-22
2010-09-30$253.00K
10-Q · filed 2012-01-27
$463.00K
derived: sum of 2 quarters · filed 2012-01-27
$739.00K
10-Q · filed 2012-01-27
2010-06-30$210.00K
10-Q/A · filed 2011-11-30
$486.00K
10-Q/A · filed 2011-11-30